BKYI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BIO-Key International Inc (BKYI) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 to invest. Despite some positive news on recent orders, the company's financial performance shows declining revenue and EPS, and technical indicators suggest the stock is overbought. Additionally, there are no strong trading signals or significant catalysts to justify immediate action.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI of 81.78 suggests the stock is overbought, which could lead to a price correction. The stock is trading near resistance levels (R1: 0.724), with limited upside potential in the short term.
BIO-Key secured a $280,000 order from a foreign defense ministry and a $1.04 million license renewal from a foreign retail bank, indicating demand for its biometric solutions. These orders contribute to over $2 million in total orders within the military and defense sector over the last year.
The company's financial performance in 2025/Q3 shows a 27.75% YoY revenue decline, a 61.54% drop in EPS, and a slight decrease in gross margin. Additionally, the stock has a high chance of declining in the short term (-0.45% in the next day, -1.45% in the next week, -3.23% in the next month).
In 2025/Q3, revenue dropped by 27.75% YoY to $1,549,706, and EPS fell by 61.54% YoY to -0.15. Net income improved by 30.57% YoY to -$964,849, but the gross margin slightly declined to 76.9%. Overall, the financial performance reflects weak growth trends.
No analyst rating or price target data available.
